Howard M Grodman, MD

Publications

Selected Publications

• Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma. Pavlos Msaouel, Andrew L. Hong, Elizabeth A. Mullen, Michael B. Atkins, Cheryl Lyn Walker, Chung Han Lee, Marcus A. Carden, Giannicola Genovese, W. Marston Linehan, Priya Rao, Maria J. Merino, Howard Grodman, Jeffrey S. Dome, Conrad V. Fernandez, James I. Geller, Andrea B. Apolo, Najat C. Daw, H. Courtney Hodges, Marva Moxey-Mims, Darmood Wei, Donald P. Bottaro, Michael Staehler, Jose A. Karam, W. Kimryn Rathmell, Nizar M. Tannir. Clinical Genitourinary Cancer
• Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue. Howard Grodman, Lawrence Wolfe, Cynthia Kretschmar. Pediatric Blood and Cancer
• Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols. Girish Dhall, Howard Grodman, Lingyun Ji, Stephen Sands, Sharon Gardner, Ira J. Dunkel, Geoffrey B. McCowage, Bianca Diez, Jeffrey C. Allen, Anjali Gopalan, Albert S. Cornelius, Amanda Termuhlen, Minnie Abromowitch, Richard Sposto, Jonathan L. Finlay. Pediatric Blood and Cancer